Radiotherapy and Sorafenib in the Management of Patients with Hepatocellular Carcinoma Have Led to Improved Survival: A Single Center Experience (original ) (raw )Management of hepatocellular carcinoma: a study on 240 patients in a single referral center
Iskren Kotzev
Scripta Scientifica Medica
View PDFchevron_right
A 30-Year, Population-Based Study Shows Improved Management and Prognosis of Hepatocellular Carcinoma
Côme Lepage
Clinical Gastroenterology and Hepatology, 2010
View PDFchevron_right
Challenges of advanced hepatocellular carcinoma
Andrea Inghilesi
World Journal of Gastroenterology, 2016
View PDFchevron_right
New advances in hepatocellular carcinoma
Sonia Pascual
World Journal of Hepatology, 2016
View PDFchevron_right
Nationwide Study of 4741 Patients With Non-B Non-C Hepatocellular Carcinoma With Special Reference to the Therapeutic Impact
Masatoshi Kudo
Annals of Surgery, 2014
View PDFchevron_right
Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice
Corrado Ficorella
BioMed Research International, 2014
View PDFchevron_right
Transarterial Chemoembolization Plus Sorafenib: A Sequential Therapeutic Scheme for HCV-Related Intermediate-Stage Hepatocellular Carcinoma: A Randomized Clinical Trial
Vincenza Conteduca
The Oncologist, 2012
View PDFchevron_right
Treatment and prognostic factors in patients with hepatocellular carcinoma
A. Martins
Liver International, 2006
View PDFchevron_right
Hepatocellular Carcinoma: An Overview of the Changing Landscape of Treatment Options
Andreas Koulouris
Journal of Hepatocellular Carcinoma
View PDFchevron_right
Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study
Taku Iida
Journal of Gastroenterology and Hepatology, 2008
View PDFchevron_right
Diagnosis and Treatment of Hepatocellular Carcinoma
Stephen Riordan
Gastroenterology, 2008
View PDFchevron_right
Treatment of hepatocellular carcinoma: beyond international guidelines
angelo sangiovanni
Liver International, 2014
View PDFchevron_right
Introduction to 2023 Chinese expert consensus on the whole-course management of hepatocellular carcinoma
Hepatoma Research
Hepatoma Research, 2024
View PDFchevron_right
European Association for the Study of the Liver Hepatocellular Carcinoma summit 2014: old questions, new (or few) answers?
Rodolfo Sacco
Future Oncology, 2014
View PDFchevron_right
Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma
Ambuj Kumar
World Journal of Hepatology, 2013
View PDFchevron_right
Management strategies for hepatocellular carcinoma: old certainties and new realities
Roberto Tarquini
Clinical and Experimental Medicine, 2015
View PDFchevron_right
Current advances made in the surgical treatment of hepatocellular carcinoma
Shah Naveed
International Surgery Journal, 2015
View PDFchevron_right
Tumor Response and Factors Affecting Survival of Using Sorafenib in Management of Advanced Hepatocellular Carcinoma
Eman Medhat
Biomedical Journal of Scientific & Technical Research, 2021
View PDFchevron_right
The Improvement in 1-Year Survival Rate of Patients with Hepatocellular Carcinoma BCLC Stage A and B after the Implementation of Comprehensive Management
saut nababan
Journal of Gastrointestinal Cancer, 2019
View PDFchevron_right
Optimal management of hepatocellular carcinoma: Challenges and opportunities
Jia-Horng Kao
Journal of Gastroenterology and Hepatology, 2010
View PDFchevron_right
Multidisciplinary approach for HCC patients: hepatology for the oncologists
giancarlo parisi
Annals of Oncology, 2013
View PDFchevron_right
Evaluation of the Efficacy of Sorafenib on Overall Survival in Patients with Hepatocellular Carcinoma using FT Rate: A Devised Index
Nobuo Toda
Advances in Therapy
View PDFchevron_right
HCC: Achieving Complete Response in a Patient After Liver Transplantation, Metastatic Hepatocellular Carcinoma with Sorafenib Treatment and Radiotherapy Continued with Follow-up
Piyush Vyas
Novel Approaches in Cancer Study, 2019
View PDFchevron_right
Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients
Franco Capra
2009
View PDFchevron_right
Hepatocellular carcinoma: Surgical perspectives beyond the barcelona clinic liver cancer recommendations
Fabiola Vazquez
View PDFchevron_right
Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000
Takashi Kumada
Cancer, 2004
View PDFchevron_right
Presentation and outcomes of hepatocellular carcinoma patients at a western centre
jm. vignesh
HPB, 2011
View PDFchevron_right
Treatment options in hepatocellular carcinoma today
Pål-Dag Line
Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society, 2011
View PDFchevron_right
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008
David Kerr
Annals of Oncology, 2009
View PDFchevron_right
Nonsurgical Management of Advanced Hepatocellular Carcinoma: A Clinical Practice Guideline
Roxanne Cosby
Current Oncology, 2020
View PDFchevron_right
Progress in surgical and nonsurgical approaches for hepatocellular carcinoma treatment
Erkan Oymacı
Hepatobiliary & Pancreatic Diseases International, 2016
View PDFchevron_right
Impact of Baseline Characteristics on the Overall Survival of HCC Patients Treated with Sorafenib: Ten Years of Experience
Patrizia Zavattari
Gastrointestinal Tumors
View PDFchevron_right
Etiology, natural history and treatment of hepatocellular carcinoma
angelo sangiovanni
Antiviral Research, 2003
View PDFchevron_right
Prognosis of Hepatocellular Carcinoma in Relation to Treatment Across BCLC Stages
José Bilbao
Annals of Surgical Oncology, 2011
View PDFchevron_right
Editorial: Interventional therapy of hepatocellular carcinoma
Ivana Vucenik
Frontiers in Molecular Biosciences
View PDFchevron_right